News

The dynamics of capital market regulation have continued to increase over the last 12 months. What has already been a reality in the EU since 2020 with the introduction of mandatory disclosure in accordance with machine readability/XBRL will now also become a regulatory obligation in Switzerland on January 1, 2024 with the implementation of the counter-proposal to the so-called corporate responsibility initiative.

The listed pharmaceutical manufacturer Dermapharm from Grünwald/Munich has been relying on ns.publish for the Annual Report 2022 or ESG Report 2022 for several months. The team around Britta Hamberger (IR) and Kai Amann (IFRS) is supported by Certified Integration Partner SPARKS CONSULTING in Munich in terms of content, creativity and also technology.

Not all companies are yet prepared for comprehensive ESG reporting. Some are waiting and watching the developments of the requirements in which form they must disclose their non-financial issues in the future. This is even though the EU and Switzerland have been defining and publishing corresponding requirements for months.